# Multi-cancer early detection (MCED)

Analytical & testing services — Multi-cancer early detection (MCED) screens asymptomatic, average-risk individuals from a single blood draw for molecular signals shared across dozens of cancer types — a population-screening scenario distinct from companion-therapy diagnostics. The technology base is circulating-DNA, methylation-pattern and protein-signal analysis. Laboratory services and screening programmes based on multi-cancer panels are procured.

Source: https://en.bioecon.ru/market/analytical-testing/multi-cancer-early-detection/